HDAC inhibitor chidamide overcomes drug resistance in chronic myeloid leukemia with the T315i mutation through the Akt–autophagy pathway

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

Andreas Hochhaus, Richard A. Larson, François Guilhot et al. · New England Journal of Medicine · 2017 · 1.3K citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +12

Computerized Quantitation of Synergism and Antagonism of Taxol, Topotecan, and Cisplatin Against Human Teratocarcinoma Cell Growth: a Rational Approach to Clinical Protocol Design

Ting‐Chao Chou, Robert J. Motzer, Yanli Tong et al. · JNCI Journal of the National Cancer Institute · 1994 · 527 citations

Medicine, Oncology, Pharmacology +13

Dexmedetomidine attenuates myocardial ischemia/reperfusion-induced ferroptosis via AMPK/GSK-3β/Nrf2 axis

Zhuoran Wang, Mengran Yao, Leyu Jiang et al. · Biomedicine & Pharmacotherapy · 2022 · 283 citations · Full text

Medicine, Cardiology, Pharmacology +16

Targeting BCR-ABL-Independent TKI Resistance in Chronic Myeloid Leukemia by mTOR and Autophagy Inhibition

Rebecca Mitchell, Lisa Hopcroft, Pablo Baquero et al. · JNCI Journal of the National Cancer Institute · 2017 · 134 citations · Full text

Medicine, Oncology, Pharmacology +15

Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia

Xian Zeng, Hui Zhao, Yubin Li et al. · Autophagy · 2015 · 90 citations · Full text

Life Sciences, Oncology, Pharmacology +17